SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041384
Filing Date
2019-11-07
Accepted
2019-11-07 08:41:11
Documents
43
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20190930.htm 10-Q 1156951
2 EX-31.1 evok-ex311_8.htm EX-31.1 9587
3 EX-31.2 evok-ex312_7.htm EX-31.2 9870
4 EX-32.1 evok-ex321_6.htm EX-32.1 5048
5 EX-32.2 evok-ex322_9.htm EX-32.2 5219
  Complete submission text file 0001564590-19-041384.txt   3303691

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evok-20190930.xml EX-101.INS 575033
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20190930.xsd EX-101.SCH 31012
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20190930_cal.xml EX-101.CAL 16652
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20190930_def.xml EX-101.DEF 74567
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20190930_lab.xml EX-101.LAB 209560
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20190930_pre.xml EX-101.PRE 155653
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 191198281
SIC: 2834 Pharmaceutical Preparations